Wells Fargo Maintains Overweight on MetLife, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Elyse Greenspan maintains an Overweight rating on MetLife (MET) but lowers the price target from $86 to $85.

May 10, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Wells Fargo maintains an Overweight rating on MetLife but reduces the price target from $86 to $85, indicating a positive outlook with a slight adjustment in valuation.
The adjustment in price target by Wells Fargo reflects a minor change in valuation expectations for MetLife. While the Overweight rating indicates a positive outlook on the stock, the reduction in price target suggests a slight tempering of expectations. This could lead to a neutral short-term impact on the stock as investors digest the minor adjustment in valuation against the backdrop of an overall positive rating.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100